Nivolumab in Treatment of Renal Cell Carcinoma During Renal Replacement Therapy

Oncology in Clinical Practice - Poland
doi 10.5603/ocp.2018.0039
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

VM Media SP. zo.o VM Group SK

Related search

Nivolumab in the Treatment of Advanced Renal Cell Carcinoma

Oncology in Clinical Practice
Oncology
2019English

Immunomodulatory Activity of Nivolumab in Metastatic Renal Cell Carcinoma

Clinical Cancer Research
Cancer ResearchOncology
2016English

Re: Nivolumab Versus Everolimus in Advanced Renal-Cell Carcinoma

European Urology
Urology
2016English

Unclassified Renal Cell Carcinoma With Significant Response to Nivolumab

Clinical Genitourinary Cancer
OncologyUrology
2017English

Renal Toxicity of Systemic Therapy for Renal Cell Carcinoma

Seminars in Nephrology
Nephrology
2020English

Complete Remission of Bone Metastases in Renal Cell Carcinoma With Nivolumab

Cureus
2019English

Targeted Therapy for Renal Cell Carcinoma

2011English

Acute Renal Replacement Therapy

International Journal of Nephrology
Nephrology
2011English

Tivozanib in the Treatment of Renal Cell Carcinoma

Biologics: Targets and Therapy
OncologyImmunologyGastroenterologyPharmacologyRheumatologyAllergy
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy